Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.220
-0.040 (-0.94%)
At close: Mar 6, 2026, 4:00 PM EST
4.163
-0.057 (-1.36%)
After-hours: Mar 6, 2026, 7:59 PM EST
Aquestive Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Aquestive Therapeutics stock have an average target of 8.83, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 109.24% from the current stock price of 4.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 7, 2025.
Analyst Ratings
The average analyst rating for Aquestive Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +89.57% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +184.36% | Oct 9, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +89.57% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +136.97% | Jun 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $15 → $7 | Buy | Initiates | $15 → $7 | +65.88% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
50.89M
from 44.55M
Increased by 14.23%
Revenue Next Year
80.58M
from 50.89M
Increased by 58.36%
EPS This Year
-0.59
from -0.78
EPS Next Year
-0.41
from -0.59
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 77.9M | 136.1M | |||
| Avg | 50.9M | 80.6M | |||
| Low | 37.2M | 50.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 74.8% | 167.5% | |||
| Avg | 14.2% | 58.4% | |||
| Low | -16.4% | -1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.27 | -0.09 | ||
| Avg | -0.59 | -0.41 | ||
| Low | -0.78 | -0.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.